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Abstract: Telocytes (TCs), commonly referred to as TCs/CD34+ stromal cells, are a peculiar type
of interstitial cells with distinctive morphologic traits that are supposed to exert several biological
functions, including tissue homeostasis regulation, cell-to-cell signaling, immune surveillance,
and reparative/regenerative effects. At present, the majority of studies investigating these cells are
mainly descriptive and focus only on their morphology, with a consequent paucity of functional
data. To gain relevant insight into the possible functions of TCs, in vitro analyses are clearly required,
but currently, the protocols for TC isolation are only at the early stages and not fully standardized.
In the present in vitro study, we describe a novel methodology for the purification of human
primary skin TCs through a two-step immunomagnetic microbead-based cell separation (i.e., negative
selection for CD31 followed by positive selection for CD34) capable of discriminating these cells
from other connective tissue-resident cells on the basis of their different immunophenotypic features.
Our experiments clearly demonstrated that the proposed method allows a selective purification
of cells exhibiting the peculiar TC morphology. Isolated TCs displayed very long cytoplasmic
extensions with a moniliform silhouette (telopodes) and presented an immunophenotypic profile
(CD31−/CD34+/PDGFRα+/vimentin+) that unequivocally differentiates them from endothelial
cells (CD31+/CD34+/PDGFRα−/vimentin+) and fibroblasts (CD31−/CD34−/PDGFRα+/vimentin+).
This novel methodology for the isolation of TCs lays the groundwork for further research aimed at
elucidating their functional properties and possible translational applications, especially in the field
of regenerative medicine.
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1. Introduction
Telocytes (TCs) are a long-neglected peculiar type of stromal cells that were firstly described by
Popescu and Faussone-Pellegrini in 2010 [1] and that have been subsequently identified, over the
last decade, in both perivascular and interstitial compartments of a variety of organs in humans and
other vertebrates [2–12]. Based on their unique ultrastructural morphology revealed by transmission
electron microscopy (TEM), TCs have been originally defined as “stromal cells with telopodes”, as they
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present a small nucleated cell body giving rise to extremely long cytoplasmic prolongations (telopodes)
with a characteristic moniliform aspect due to the alternation of very slender segments (podomers)
and bead-like dilated portions (podoms) accommodating mitochondria, endoplasmic reticulum
cisternae, and caveolae [1,2,5,10]. TCs are able to release a variety of extracellular microvesicles
containing bioactive molecules and, through their telopodes, they form complex three-dimensional
networks within the stromal compartment of different organs, either by interconnecting to each other
or establishing multiple cell–cell contacts with other cell types, such as immune cells, muscle fibers,
blood vessels, and epithelial cells [5,10,13,14]. Given their peculiar morphology, spatial distribution,
and secretory abilities, TCs have been proposed to exert multiple functional roles in their resident tissues,
including structural support and tissue organization during development and post-natal homeostasis,
juxtacrine and paracrine cell-to-cell signaling, immune surveillance, and reparative/regenerative effects
by supporting local stem cell niche maintenance and differentiation [2,4,5,15–23].
Although the lack of TC-specific antigenic markers still makes TEM the gold-standard technique
to identify TCs within tissues, increasing evidence demonstrates that TCs from virtually every
human organ consistently express the cell surface glycoprotein CD34, making them detectable also by
immunohistochemical analyses [5–7,10,11]. Indeed, according to substantial literature, TCs are also
commonly referred to as TCs/CD34+ stromal cells [6,7,20]. However, as CD34 expression is not exclusive
to TCs, when immunolocalizing these cells by light microscopy, it is preferable to use a combination
of multiple markers. In particular, since CD34 is strongly expressed also by vascular endothelial cells
(ECs), CD34/CD31 double immunostaining has been proven to be extremely useful to unequivocally
distinguish between CD34+/CD31− TCs and CD34+/CD31+ ECs of blood vessels, especially considering
that the latter, when captured in tissue sections, may often exhibit an elongated profile resembling
that of TCs [7–9,24,25]. Another marker commonly used to identify TCs by immunohistochemistry is
platelet-derived growth factor receptor (PDGFR)α that has been demonstrated to be coexpressed with
CD34 in TCs from different organs [5,8–11,25–27].
Given the extensive distribution of TC interstitial networks in different organs and the numerous
putative roles attributed to these stromal cells, increasing literature has hypothesized that their
phenotypic and functional alterations may be implicated in different pathologic conditions [28–31].
Indeed, recent studies have reported a reduction in TCs and severe structural changes in the TC
stromal network in a variety of disorders, including heart failure and conditions characterized by
chronic tissue inflammation and/or fibrotic remodeling, such as psoriasis, primary Sjögren’s syndrome,
Crohn’s disease, ulcerative colitis, systemic sclerosis, and liver fibrosis [24,28,32–38].
Despite the growing belief that TCs may exert important roles in both physiologic and pathologic
conditions, at present, the majority of studies investigating these cells are mainly descriptive and focus
only on their morphology, with a consequent paucity of functional data. To gain relevant insight
into the possible functions of TCs, in vitro analyses are clearly required, but currently, the protocols
for TC isolation are only at early stages and not fully standardized [39–46]. The present study was,
therefore, undertaken to develop, for the first time, a methodology for the selective in vitro isolation of
human primary TCs/CD34+ stromal cells consisting in a two-step immunomagnetic microbead-based
separation of these cells from two other stromal cell populations, namely ECs and fibroblasts.
2. Results
2.1. TC Purification from Healthy Human Skin and In Vitro Assessment of Cell Morphology
In order to establish a TC purification protocol required to allow reliable future in vitro
investigations, we designed a two-step immunomagnetic cell separation method based on our
current knowledge of the immunophenotypic features of these cells [6–9]. Since the most widely
used TC marker, namely CD34, is also expressed by ECs, the first step of the protocol consisted of
a microbead-based cell selection for the pan-endothelial cell surface marker CD31, also known as
platelet/endothelial cell adhesion molecule-1, to separate CD31+ cells (i.e., putative ECs) from CD31−
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cells (Figure 1). The second step, performed on the pool of the remaining CD31− cells, allowed their
further selection on the basis of the expression of the CD34 cell surface antigen to purify CD31−/CD34+
cells (i.e., putative TCs) from CD31−/CD34− cells (i.e., putative fibroblasts) (Figure 1). Given the ease
of collection, to set up our protocol for the isolation of primary TCs/CD34+ stromal cells, we employed
specimens of healthy human skin, a tissue in which these peculiar cells have been reported to be
widely distributed throughout the dermal layer, where they intimately surround vessels and skin
appendages, and establish numerous intercellular communications with neighboring cells, including
fibroblasts [34,47–50].
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Figure 1. Schematic representation of the t o agnetic microbead-based cell sep ration
protocol. Total dermal ce ls obtained from the processing of healthy human skin sample were ubj cted
to magnetic-activ ted cell sorting s paration. The first step was carried out in order to isolate CD31+
cells (i.e., putative endothelial cells), while the second step, performed on the pool of the remaining
CD31− cells, allowed the further separation of CD31−/CD34+ cells (i.e., putative telocytes) from
CD31−/CD34− cells (i.e., putative fibroblasts).
Int. J. Mol. Sci. 2020, 21, 5877 4 of 16
The identity of the three different immunomagnetically purified cell populations (CD31+ putative
ECs, CD31−/CD34+ putative TCs, and CD31−/CD34− putative fibroblasts) was firstly evaluated
by placing them into culture and subsequently, assessing their specific cell morphology using both
phase-contrast microscopy and wheat germ agglutinin (WGA) fluorescent staining. As shown in
Figure 2A,B, CD31−/CD34+ sorted cells presented the distinctive TC morphology, with a small nucleated
cell body, from which extremely long and moniliform cytoplasmic prolongations (telopodes) abruptly
arise. Conversely, CD31+ cells exhibited the characteristic polygonal cobblestone-like morphology of
ECs (Figure 2C), while CD31−/CD34− cells showed the typical spindle shape of fibroblasts, with shorter
and thicker non-moniliform cytoplasmic prolongations (Figure 2D).
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Figure 2. Morphologic assessment of in vitro cultured CD31−/CD34+, CD31+, and CD31−/CD34−
immunomagnetically selected cells by phase-contrast microscopy. (A,B) Representative phase-contrast
microphotographs of CD31−/CD34+ purified cells showing the distinctive telocyte morphology, with a
small nucleated cell body giving rise to extremely long cytoplasmic prolongations with a moniliform
appearance (i.e., telopodes). (C) Representative phase-contrast microphotograph of CD31+ isolated
cells exhibiting the characteristic polygonal cobblestone-like morphology of ECs. (D) Representative
phase-contrast microphotograph of CD31−/CD34− isolated cells presenting the typical spindle shape
of fibroblasts. Original magnification: ×20 (A–D). Scale bar: 100 µm (A–D).
To further characterize the morphologic features of the three isolated and in vitro cultured cell
populations, we next performed WGA fluorescent staining. Indeed, WGA conjugates have the ability
to bind the cellular glycocalyx and, therefore, are routinely used to label the plasma membrane
highlighting the cellular shape. As displayed in Figure 3, cell morphologies detected by WGA staining
were comparable to those observed by phase-contrast microscopy. In particular, CD31−/CD34+ purified
cells exhibited very long cytoplasmic prolongations with a clear moniliform aspect conferred by the
alternation of slender segments and bead-like dilated portions, which are distinctive features of TCs
(Figure 3A–D). Similarly, CD31+ and CD31−/CD34− isolated cells stained with WGA presented the
typical morphologic characteristics of ECs (Figure 3E) and fibroblasts (Figure 3F), respectively.
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2.2. Immunophenotypic Characterization of In Vitro Cultured CD31−/CD34+, CD31+, and CD31−/CD34− 
Immunomagnetically Selected Cells 
Figure 3. Morphologic assessment of in vitro cultured CD31−/CD34+, CD31+, and CD31−/CD34−
immunomagnetically selected cells by staining of the cell membrane with fluorescent wheat germ
agglutinin. (A–D) Representative fluorescent microscopic images of CD31−/CD34+ isolated cells
exhibiting the distinctive telocyte morphology, with a small cell body and long cytoplasmic prolongations
(i.e., telopodes) presenting a moniliform aspect conferred by the alternation of slender segments
(podomers) and bead-like dilated portions (podoms). Telocytes are heterogeneous in the shape of
their cell body that gives rise to a variable number of telopodes. (D) A higher magnification view
of the telopode pointed by the arrow is shown in the inset. (E) Representative fluorescent image of
CD31+ isolated cells with the characteristic polygonal cobblestone-like morphology of endothelial
cells. (F) Representative fluorescent image of CD31−/CD34− isolated cells presenting the typical
spindle shape of fibroblasts, with shorter and thicker non-moniliform cytoplasmic prolongations.
The fibroblast prolongation pointed by the arrow is shown at higher magnification in the inset.
Nuclei are counterstained in blue with 4′,6-diamidino-2-phenylindole (DAPI). Original magnification:
×10 (A), ×20 (B–F). Scale bar: 200 µm (A), 100 µm (B–F).
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2.2. Immunophenotypic Characterization of In Vitro Cultured CD31−/CD34+, CD31+, and CD31−/CD34−
Immunomagnetically Selected Cells
In order to confirm the effectiveness of our immunomagnetic separation protocol, the three different
isolated cell populations were further subjected to a verification of their immunophenotypic profile
through CD31/CD34 double immunofluorescence staining. As shown in Figure 4A–C, cells negatively
selected for CD31 during the first step of purification and subsequently subjected to CD34 positive
selection were effectively immunolabeled only with the anti-CD34 antibody and displayed the typical
TC morphology. Cells negatively selected for both CD31 and CD34 (i.e., fibroblasts) resulted completely
unlabeled. Finally, CD31+ selected cells were found to coexpress CD31 and CD34, thus, confirming their
EC identity (Figure 4D).
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The immunophenotype of the three different immunomagnetically purified cell populations 
was further assessed through the analysis of the protein expression of CD31, CD34, PDGFRα, and 
vimentin by Western blotting. According to the immunofluorescence findings, cells positively 
selected for CD31 (i.e., ECs) were found to express both CD31 and CD34 proteins, while cells 
Figure 4. Verification of the immunophenotypic profile of in vitro cultured CD31−/CD34+ and CD31+
immunomagnetically selected cells by CD31/CD34 double immunofluorescence. (A–C) Representative
fluorescent microscopic images of CD31−/CD34+ immunomagnetically selected cells double
immunostained for CD34 (green) and CD31 (red). The cells express only CD34 and are morphologically
identifiable as telocytes with typical telopodes. The cell body of telocytes varies in shape, being oval,
triangular, or spindle-shaped, and gives rise to a variable number of telopodes. (B) Note the presence
of telocytes establishing intercellular contacts with their telopodes. (D) Representative fluorescent
image of CD31+ immunomagnetically selected cells double immunostained for CD34 (green) and
CD31 (red). All cells coexpress CD31 and CD34 and display the typical polygonal cobblestone-like
morphology of endothelial cells. Note the distinctive localization of the CD31 antigen at regions of
intercellular contacts. Nuclei are counterstained in blue with 4′,6-diamidino-2-phenylindole (DAPI).
Original magnification: ×20 (A), ×40 (B–D). Scale bar: 100 µm (A), 50 µm (B–D).
The purity of immunomagnetically isolated CD31−/CD34+ TCs was ≥90%, as assessed by
determining the percentage of cells immunolabeled for CD34, but not CD31, and displaying the typical
TC morphology with respect to the total number of cells identified by DAPI-labeled nuclei.
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The immunophenotype of the three different immunomagnetically purified cell populations was
further assessed through the analysis of the protein expression of CD31, CD34, PDGFRα, and vimentin
by Western blotting. According to the immunofluorescence findings, cells positively selected for CD31
(i.e., ECs) were found to express both CD31 and CD34 proteins, while cells negatively selected for
CD31 during the first step of immunomagnetic purification and then, subjected to positive selection
for CD34 (i.e., TCs) expressed CD34 but not CD31 (Figure 5). Western blotting analysis also confirmed
that in CD31−/CD34− immunomagnetically selected cells (i.e., fibroblasts), neither of the two antigens
were expressed (Figure 5). As far as PDGFRα expression is concerned, it was detected in both TCs and
fibroblasts, but not in ECs (Figure 5). Of note, in agreement with substantial literature [5,8–11,25–27,51],
the coexpression of CD34 and PDGFRα further confirmed that the CD31−/CD34+ immunomagnetically
selected cell population consisted of TCs (Figure 5). We also evaluated the protein expression of
vimentin, a marker that is often used to stain TCs [4,43,52]. As shown in Figure 5, vimentin protein
was found in all the three isolated cell populations, which is consistent with the evidence that this
marker is widely expressed by all cells of mesenchymal origin, including TCs, fibroblasts as well as
ECs, which indeed are the only mesenchyme-derived epithelial cell type [53,54].
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Figure 5. Western blotting analysis of CD31, CD34, platelet-derived growth factor receptor (PDGFR)α,
and vimentin protein expression in CD31+ (endothelial cells), CD31−/CD34+ (telocytes), and CD31−/CD34−
(fibroblasts) immunomagnetically selected cells. Protein lysates of the three different immunomagnetically
purified cell populations were assayed for the expression of CD31, CD34, PDGFRα, and vimentin.
Representative im unoblots are shown. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was
measured as a loading control. Molecular weight values (kDa) are indicated on the right. M—molecular
weight marker.
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Finally, we performed double immunofluorescence staining to confirm the coexpression of CD34
and PDGFRα in isolated TCs displaying typical telopodes (Figure 6).Int. J. Mol. Sci. 2020, 21, x FOR PEER REVIEW 8 of 16 
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Figure 6. Coexpression of CD34 and PDGFRα in isolated telocytes assessed by double immunofluorescence.
(A–I) Representative fluorescent microscopic images of purified telocytes double immunostained for CD34
(green) and PDGFRα (red). Single green (A,D,G), single red (B,E,H) and merged (C,F,I) images are shown.
Nuclei are counterstained in blue with 4′,6-diamidino-2-phenylindole (DAPI). Original magnification:
×20 (A–C), ×40 ( –I). Scale bar: 100 µm (A–C), 50 µm (D–I).
3. Discussion
The present in vitro study describes a novel methodology for the selective purification of human
primary TCs/CD34+ stromal cells through a two-step immunomagnetic microbead-based cell separation
capable of discriminating these cells from ther connective tissue-resident cells (i.e., ECs and fibroblasts)
on the basis of their different immunophenotypic profile. Indeed, we clearly demonstrate that TCs
can be easily i olated from human althy ski and that, when cultured, these c lls exhibit their
peculiar morphology, with very long telopo es. Moreover, we also provi e evidence tha magnetically
isolated TCs are CD31−/CD34+/PDGFRα+/vimentin+, immunophenotypic f atu es that are consistent
with the current literature [5–11,24–27,51], and clearly differentiate these stromal cells from ECs
(CD31+/CD34+/PDGFRα−/vimentin+) and fibroblasts (CD31−/CD34−/PDGFRα+/vimentin+). Of note,
TCs from some organs have also been shown to express CD117/c-kit [5,7]. However, here, CD117/c-kit
was not included in the TC molecular profiling because in a previous work, we have clearly demonstrated
that dermal TCs/CD34+ stromal cells are negative for this marker [34].
Isolation and culture expansion of TCs are of great interest in the perspective of allowing future
reliable morphofunctional in vitro investigations to gain fundamental insight into the functions of
these peculiar type of interstitial cells. In fact, the majority of studies that have so far investigated
TCs in physiologic and pathologic tissues are mainly descriptive and focused on the ultrastructural,
morphologic, and immunophenotypic characterization of these cells within their resident tissues,
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leaving much of their proposed functions still a matter of debate [22,29,55,56]. In this regard,
the ability of TCs to form complex interstitial networks and communicate with neighboring cells
by establishing multiple intercellular contacts or releasing extracellular vesicles containing bioactive
molecules, together with the evidence that such TC networks are severely impaired in a variety of
pathologies, led to proposing that these cells may exert a wide spectrum of functions important for
the maintenance of tissue homeostasis [2,4,5,10,28,29,57,58]. For instance, owing to their strategic
position in relation to tissue-resident stem cell niches in various organs and satellite cells in the
skeletal muscle, it has been postulated that TCs may play a pivotal role in stem cell survival,
proliferation, differentiation, maturation, and guidance, eventually stimulating tissue regenerative
processes [5,19,52,59–62]. Furthermore, TCs are usually found to intimately surround microvessels with
their telopodes and may express proangiogenic growth factors, such as vascular endothelial growth
factor, and several microRNAs with angiogenic functions, suggesting that they may influence EC
functions contributing to vascular homeostasis and neovascularization processes [41,63,64]. TCs might
also have an active role in immunomodulation/immune surveillance, as they have been described to
establish cell-to-cell contacts with immune cells and to be damaged and reduced in different pathologies
characterized by acute or chronic inflammation such as salpingitis, psoriasis, and inflammatory bowel
diseases [3,5,24,35,36,65,66]. Ultrastructural alterations and loss of TCs have also been reported during
fibrotic tissue remodeling, which led to attributing them a possible role in the regulation of neighboring
fibroblast functionality [28,34,37,38]. In addition, TCs seem to possess electrophysiologic properties,
as reported in myometrium, myocardium, and the enteric neuromuscular compartment, where they
have been proposed to contribute to the spreading of the slow waves generated by the pacemaker
interstitial cells of Cajal [2,5,26,44,58,67,68]. In light of the above, it is clear that the possibility to use
purified and in vitro expanded TCs in coculture with other cell populations, including stem cells,
ECs, immune cells, and fibroblasts, may represent an extremely useful tool to definitively unravel
the effective functional roles and implications of these stromal cells in different pathologic conditions.
Of note, over the past few years, several attempts have been made to isolate TCs from various organs
such as the uterus [39,44,46], lung [45], and heart [41–43]. Nevertheless, it is important to consider
that all these studies discerned TCs only on the basis of their different adhesion time on the plate,
placing into culture the cells remaining in suspension after fibroblast attachment [39–46] and assessing
their immunophenotype only subsequently [40,44,46]. In this context, our cell purification approach,
which consists in the selection of TCs immediately after tissue processing and according to their
immunophenotypic profile, may represent an innovative, reliable, and reproducible method to obtain
a pure TC population suitable for in vitro analyses and other applications.
Indeed, besides allowing an in-depth comprehension of their morphofunctional characteristics,
effective protocols for the isolation of TCs appear even more essential, especially when considering that
these stromal cells are increasingly gaining attention as possible candidates in the field of regenerative
medicine [5,10,52,55]. Interestingly, tissue regenerative and therapeutic effects of TCs have already
been demonstrated in a few in vivo studies reporting that intramyocardial transplantation of these cells
in post-infarcted rats was able to decrease the infarct size and improve cardiac functions [69,70]. Finally,
as recently proposed [71], the establishment of novel reliable methodologies for TC purification and
in vitro expansion represents a prerequisite for the possible application of these cells in the setting up
of three-dimensional model systems, such as engineered tissue/organ equivalents, which are emerging
as innovative tools for translational research purposes.
In conclusion, in the present in vitro study, we established a simple and efficient method to obtain
a pure population of human TCs that has the great potential to become an important tool for elucidating
the biological effects and the possible research applications of these cells. Since, to develop this novel
methodology, we employed human skin specimens, we are aware that further studies will be necessary
to validate the efficiency and reproducibility of our immunomagnetic cell separation technique for
the purification of TCs from different anatomical compartments. In addition, it should be pointed
out that, in order to verify the effectiveness of our TC purification method, we herein analyzed cell
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morphology and molecular profile immediately after separation at first passages in culture. Therefore,
in the perspective of employing isolated TCs in functional assays, it will be also necessary to assess if
these cells are able to maintain their morphology and immunophenotype in long-term cultures.
4. Materials and Methods
4.1. Skin Sample Collection
Skin samples were collected as waste material from plastic surgery of six healthy subjects at the
Plastic and Reconstructive Microsurgery Center, Careggi University Hospital, Florence, Italy. The study
was approved by the Comitato Etico Regionale per la Sperimentazione Clinica della Toscana—sezione
AREA VASTA CENTRO, Florence, Italy (approval number: 16687_bio; approval date: 14 April 2020),
and all subjects provided written informed consent. All steps were carried out under a biological hood
and under sterile conditions. Skin samples, collected and transported in full growth medium composed
of Dulbecco’s modified eagle medium (DMEM; catalog no. 11965084; Thermo Fisher Scientific, Waltham,
MA, USA) supplemented with 10% fetal bovine serum (FBS), 100 U/mL of penicillin, and 100 U/mL
streptomycin (catalog no. 15140122; Thermo Fisher Scientific, Waltham, MA, USA), were immediately
processed or kept at 37 ◦C in a humidified CO2 incubator set to 5% CO2 for a maximum of 24 h
until processing.
4.2. Skin Sample Processing and Cell Extraction
Skin samples were removed from the medium and transferred, with the dermis facing upwards,
in a sterile 100 mm Petri dish. After removing any remaining adipose tissue and damaged zones
with a sterile scalpel, to reduce the risks of contamination, skin samples were retrieved with clean
sterile tweezers and placed in a new sterile Petri dish with the epidermis on the top. Skin samples
were, then, cut into small pieces of approximately 3 mm using a scalpel and successively covered and
incubated in 7 mL of a dispase solution (5 U/mL; catalog no. 07913; Stemcell Technologies, Vancouver,
Canada) overnight at 4 ◦C. After the incubation, skin samples were transferred into a new sterile
Petri dish and, while maintaining the dermis in place with tweezers, the epidermis was delicately
and slowly peeled off the dermis using thin curved tweezers and discarded. The remaining dermic
pieces were collected in a 15 mL conical tube containing endothelial cell growth basal medium-2
(EBM-2; catalog no. CC-3156; Lonza, Basel, Switzerland) supplemented with 5% FBS and 0.015 g/mL
collagenase (catalog no. C0130; Merck, Darmstadt, Germany) and incubated for 60 min at 37 ◦C in a
thermostated water bath. After centrifuging at 300× g for 7 min to remove collagenase and placing
the tissue pellet in a new Petri, a sterile slide was placed over the tissue pieces, slightly pushed, and
overlaid with full growth medium. Cells were let to adhere to the Petri dish for a minimum of 24 h
before slide removal and subsequently, subjected to magnetic-activated cell sorting (MACS) separation.
4.3. Two-Step Immunomagnetic Microbead-Based Cell Separation
Before proceeding to microbead-based cell separation, total cells were trypsinized, counted,
centrifuged at 300× g for 7 min, and finally, resuspended to a maximum concentration of 1 × 107 cells
in 60 µL of starvation medium (EBM-2 basal medium supplemented with 2% FBS). For the isolation of
the different cell populations (i.e., CD31+ ECs, CD31−/CD34+ TCs, and CD31−/CD34− fibroblasts),
microbead-based cell separation was performed in two steps. The first step was carried out in order to
isolate CD31+ cells (i.e., ECs), while the second step, performed on the remaining CD31− cells, allowed
further separation of CD31−/CD34+ cells (i.e., TCs) from CD31−/CD34− cells (i.e., fibroblasts).
4.3.1. CD31+ Endothelial Cell Isolation
CD31+ ECs were purified using the CD31 MicroBead Kit (catalog no. 130-091-935; Miltenyi Biotec,
Bergisch Gladbach, Germany). Briefly, 20 µL of FcR Blocking reagent was added to total cell suspension
and, after vortexing, cells were incubated with 20 µL of CD31 microbeads for 15 min at 4 ◦C. At the
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end of incubation, 1 mL of starvation medium was added to cell suspension, which was subsequently
centrifuged at 300× g for 7 min, resuspended in 500 µL of starvation medium, and finally, subjected to
magnetic separation. In particular, separation columns were placed in the magnetic field of a MACS
Separator and washed with 3 mL of starvation medium before adding cell suspension. MACS columns
contain a matrix composed of magnetic spheres covered with a cell-friendly coating. The space among
the spheres is much larger than the size of the cells, allowing a free passage inside the column. When the
column is placed in the MACS Separator, the strong magnetic field induced and amplified by the spheres
within the column retains magnetic labeled cells, which do not bind directly to the column, but remain
suspended within it, thus, undergoing reduced stress. Unlabeled cells (CD31− cells) were directly
collected from the column effluent after three washes with 500 µL of starvation medium (negative
selection), while magnetically labeled CD31+ cells were eluted from the columns by firmly pushing a
plunger into the column outside the magnet (positive selection). CD31+ positive cells were cultured
in EGM-2 MV complete medium (EGM-2 MV Microvascular Endothelial Cell Growth Medium-2
BulletKit; catalog no. CC-3202; Lonza, Basel, Switzerland), while CD31− cells were subjected to a second
magnetic separation.
4.3.2. CD31−/CD34+ Telocyte Isolation
CD31−/CD34+ TCs were isolated using the CD34 MicroBead Kit (catalog no. 130-046-702; Miltenyi
Biotec, Bergisch Gladbach, Germany). Briefly, for positive selection, CD31− cells obtained from the
first magnetic separation were centrifuged at 300× g for 7 min and resuspended in 300 µL of a buffer
containing phosphate-buffered saline (PBS; pH 7.2), 0.5% FBS, and 2 mM ethylenediaminetetraacetic
acid (EDTA). Cells were then incubated with 100 µL of FcR blocking buffer and 100 µL of CD34
microbeads for 30 min at 4 ◦C. Cells were washed by adding 5 mL of buffer and centrifuged at 300× g
for 7 min. After aspirating the supernatant, cells were resuspended in 500 µL of buffer and subjected to
the second magnetic separation. Unlabeled cells (CD31−/CD34− cells, i.e., fibroblasts) were directly
collected from the column effluent after three washes with 500 µL of buffer (negative selection),
while magnetically labeled cells (CD31−/CD34+ cells, i.e., TCs) were eluted from the columns by
firmly pushing a plunger into the column outside the magnet (positive selection). TCs and fibroblasts
were finally cultured in full growth medium composed of DMEM supplemented with 10% FBS,
2 mM l-glutamine (catalog no. BE17-605E/U1; Lonza, Basel, Switzerland), 100 U/mL of penicillin,
and 100 U/mL streptomycin.
4.4. Cell Culture
CD31+ ECs, CD31−/CD34+ TCs, and CD31−/CD34− fibroblasts were cultured and maintained
in 100 mm Petri dishes with the corresponding full growth medium until second passage. To assess
cell morphology, after the first passage, phase-contrast images of the three cell populations were
obtained under a Leica inverted microscope (Leica Microsystems, Mannheim, Germany) equipped
with a digital camera.
4.5. Fluorescence Immunocytochemistry
ECs, TCs, and fibroblasts at the second passage in culture were seeded onto glass coverslips and
fixed with 3.7% buffered paraformaldehyde. In order to confirm the efficacy of magnetic isolation of the
three different cell populations, the expression of CD31 and CD34 markers was assessed by fluorescence
immunocytochemistry. In particular, cells were permeabilized with 0.1% Triton X-100 in PBS, washed with
PBS, and blocked with 1% bovine serum albumin in PBS for 1 h at room temperature. After blocking,
cells were incubated overnight at 4 ◦C with mouse monoclonal anti-CD31 (catalog no. ab9498; Abcam,
Cambridge, UK) and rabbit monoclonal anti-CD34 (catalog no. ab81289; Abcam, Cambridge, UK)
antibodies, both at 1:50 dilution. The day after, slides were incubated in the dark for 45 min at
room temperature with Rhodamine Red-X-conjugated anti-mouse and Alexa Fluor-488-conjugated
anti-rabbit IgG (Invitrogen, Carlsbad, CA, USA) diluted 1:200. Double immunofluorescence staining was
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performed by mixing mouse anti-CD31 and rabbit anti-CD34 primary antibodies and subsequently mixing
fluorochrome-conjugated secondary antibodies. Irrelevant isotype-matched and concentration-matched
mouse and rabbit IgG (Sigma-Aldrich, St. Louis, MO, USA) were used as negative controls. Nuclei were
counterstained with 4′,6-diamidino-2-phenylindole (DAPI). Immunolabeled cells were examined with a
Leica DM4000 B microscope (Leica Microsystems, Mannheim, Germany) and fluorescence images were
captured with a Leica DFC310 FX 1.4-megapixel digital color camera equipped with the Leica software
application suite LAS V3.8 (Leica Microsystems, Mannheim, Germany). The same double fluorescence
immunocytochemistry protocol was applied to assess the coexpression of CD34 and PDGFRα in isolated
TCs by using rabbit anti-CD34 (1:50 dilution; catalog no. ab81289; Abcam, Cambridge, UK) in combination
with mouse anti-PDGFRα (1:50 dilution; catalog no. ab35765; Abcam, Cambridge, UK). To estimate the
purity of the immunomagnetically isolated CD31−/CD34+ TCs, the percentage of cells displaying both
the CD31−/CD34+ immunophenotype and the characteristic TC morphology with respect to the total
number of cells (i.e., cells with DAPI-labeled nuclei) was determined by cell counting in fifteen randomly
chosen microscopic fields (20× original magnification) of each of the two CD31/CD34-immunostained
slides per sample.
4.6. Wheat Germ Agglutinin Fluorescent Staining
To stain plasma membranes of cells at the second passage in culture, paraformaldehyde-fixed
slides were rinsed in PBS and incubated for 10 min at room temperature in the dark with Alexa
Fluor-488-conjugated WGA (catalog no. W11261; Thermo Fisher Scientific, Waltham, MA, USA) at
1:100 dilution. Nuclei were counterstained with DAPI.
4.7. Western Blotting
Whole cell protein lysates from the three cell populations at the second passage in culture were
subjected to immunoblot analysis according to previously published protocols [72]. The following
antibodies were used: Rabbit anti-CD31 (1:500 dilution; catalog no. ab28364; Abcam, Cambridge, UK),
rabbit anti-CD34 (1:1000 dilution; catalog no. ab81289; Abcam, Cambridge, UK), mouse anti-PDGFRα
(1:500 dilution; catalog no. ab35765; Abcam, Cambridge, UK), mouse anti-vimentin (1:1000 dilution; catalog
no. M7020; Dako, Glostrup, Denmark), and mouse anti-glyceraldehyde 3-phosphate dehydrogenase
(GAPDH; 1:5000 dilution; catalog no. ab8245; Abcam, Cambridge, UK). Immunodetection was performed
using the Western Breeze Chromogenic Western Blot Immunodetection Kit (Invitrogen, Carlsbad, CA,
USA) as described elsewhere [72].
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63. Manole, C.G.; Cismaşiu, V.; Gherghiceanu, M.; Popescu, L.M. Experimental acute myocardial infarction:
Telocytes involvement in neo-angiogenesis. J. Cell. Mol. Med. 2011, 15, 2284–2296. [CrossRef] [PubMed]
64. Zhou, Y.; Yang, Y.; Liang, T.; Hu, Y.; Tang, H.; Song, D.; Fang, H. The regulatory effect of microRNA-21a-3p on
the promotion of telocyte angiogenesis mediated by PI3K (p110α)/AKT/mTOR in LPS induced mice ARDS.
J. Transl. Med. 2019, 17, 427. [CrossRef] [PubMed]
65. Popescu, L.M.; Gherghiceanu, M.; Cretoiu, D.; Radu, E. The connective connection: Interstitial cells of Cajal
(ICC) and ICC-like cells establish synapses with immunoreactive cells. Electron microscope study in situ.
J. Cell. Mol. Med. 2005, 9, 714–730. [CrossRef]
66. Yang, J.; Chi, C.; Liu, Z.; Yang, G.; Shen, Z.J.; Yang, X.J. Ultrastructure damage of oviduct telocytes in rat
model of acute salpingitis. J. Cell. Mol. Med. 2015, 19, 1720–1728. [CrossRef]
Int. J. Mol. Sci. 2020, 21, 5877 16 of 16
67. Cretoiu, S.M.; Cretoiu, D.; Marin, A.; Radu, B.M.; Popescu, L.M. Telocytes: Ultrastructural, immunohistochemical
and electrophysiological characteristics in human myometrium. Reproduction 2013, 145, 357–370. [CrossRef]
68. Sheng, J.; Shim, W.; Lu, J.; Lim, S.Y.; Ong, B.H.; Lim, T.S.; Liew, R.; Chua, Y.L.; Wong, P. Electrophysiology of
human cardiac atrial and ventricular telocytes. J. Cell. Mol. Med. 2014, 18, 355–362. [CrossRef]
69. Zhao, B.; Liao, Z.; Chen, S.; Yuan, Z.; Yilin, C.; Lee, K.K.; Qi, X.; Shen, X.; Zheng, X.; Quinn, T.; et al.
Intramyocardial transplantation of cardiac telocytes decreases myocardial infarction and improves post-infarcted
cardiac function in rats. Cell. Mol. Med. 2014, 18, 780–789. [CrossRef]
70. Zhao, B.; Chen, S.; Liu, J.; Yuan, Z.; Qi, X.; Qin, J.; Zheng, X.; Shen, X.; Yu, Y.; Qnin, T.J.; et al. Cardiac telocytes
were decreased during myocardial infarction and their therapeutic effects for ischaemic heart in rat.
Cell. Mol. Med. 2013, 17, 123–133. [CrossRef]
71. Manetti, M.; Matucci-Cerinic, M. In search for the ideal anatomical composition of vascularised human skin
equivalents for systemic sclerosis translational research: Should we recruit the telocytes? Ann. Rheum. Dis.
2019. [CrossRef]
72. Manetti, M.; Romano, E.; Rosa, I.; Fioretto, B.S.; Guiducci, S.; Bellando-Randone, S.; Pigatto, E.; Cozzi, F.;
Ibba-Manneschi, L.; Matucci-Cerinic, M. Systemic sclerosis serum significantly impairs the multi-step
lymphangiogenic process: In vitro evidence. Int. J. Mol. Sci. 2019, 20, 6189. [CrossRef] [PubMed]
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
